Among the immune receptors, the triggering receptor expressed on myeloid cells-1 (TREM-1) has been increasingly explored in infectious diseases, including viral infections, due to its role in the amplification of inflammatory responses, and is now considered as a promising therapeutic target and diagnostic/prognostic biomarker in different scenarios [39,40,41]. This evidence concerns the gene TREM1 and viral infectious disease.